Seer Inc (SEER)
1.90
+0.15
(+8.57%)
USD |
NASDAQ |
Apr 26, 13:28
Seer Profit Margin (Quarterly): -425.8% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -425.8% |
| September 30, 2023 | -552.9% |
| June 30, 2023 | -675.2% |
| March 31, 2023 | -644.4% |
| December 31, 2022 | -583.4% |
| September 30, 2022 | -606.3% |
| Date | Value |
|---|---|
| June 30, 2022 | -638.9% |
| March 31, 2022 | -717.0% |
| December 31, 2021 | -651.0% |
| September 30, 2021 | -857.1% |
| June 30, 2021 | -1.37K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.37K%
Minimum
Jun 2021
-425.8%
Maximum
Dec 2023
-701.6%
Average
-644.4%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Candel Therapeutics Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.54% |
| Return on Assets | -18.73% |
| Return on Invested Capital | -20.54% |
| Gross Profit Margin (Quarterly) | 41.70% |
| Operating Margin (Quarterly) | -531.9% |
| Return on Net Operating Assets | -147.4% |